YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
Q2 Earnings Roundup: UFP Technologies (NASDAQ:UFPT) And The Rest Of The Drug Development Inputs & Services Segment The end of the earnings season is always a good time to take a step back and see who shined (and who didn't). Let's take a l…
Brings a proven track record of shareholder value creation from more than three decades leading UFP Technologies through portfolio transformation, manufacturing excellence initiatives, and 20+ M&A transactions Adds valuable expertise in me…
UFP Technologies has seen a powerful run in its share price in recent years, which naturally raises a question for anyone looking at the stock today. Is the current valuation supported by the company's earnings, or has sentiment moved ahea…
Tributary Capital Management released its second-quarter 2026 investor letter for "Multi Cap Core Equity Strategy". You can download a copy of the letter here. The Tributary Multi Cap Core's equity allocation underperformed in Q2, returnin…
3 Russell 2000 Stocks That Concern Us The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size also means these businesses often lack the r…
1 Cash-Producing Stock for Long-Term Investors and 2 We Find Risky A company that generates cash isn't automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. Luckily for you, w…
Q2 Earnings Review: Drug Development Inputs & Services Stocks Led by Azenta (NASDAQ:AZTA) As the Q2 earnings season wraps, let's dig into this quarter's best and worst performers in the drug development inputs & services industry, includin…
For Immediate Release Chicago, IL – September 10, 2026 – Today, Zacks Equity Research discusses Veracyte VCYT, Globus Medical GMED and UFP Technologies UFPT. Industry: Medical Instruments Link: https://www.zacks.com/commentary/2986737/3-me…
Investors in UFP Technologies, Inc. UFPT need to pay close attention to the stock based on moves in the options market lately. That is because the Oct. 16, 2026 $200.00 Put had some of the highest implied volatility of all equity options t…
Generative AI (GenAI) is gaining practical applications across the Medical Instruments industry, moving beyond its experimental phase. Companies are using it to generate synthetic medical images, simulate disease progression, create potent…
On August 3, UFP Technologies (NASDAQ:UFPT) reported second-quarter net income of $20.9 million, up 21.4% from $17.2 million a year earlier, alongside net sales of $174.0 million, a 15.1% jump from $151.2 million. Both figures, along with…
Cynthia L. Feldmann, a Director at UFP Technologies (NASDAQ:UFPT), sold 1,000 shares of common stock on Aug. 13, 2026, according to a SEC Form 4 filing. Transaction summary Metric Value Transaction value $324,260 Shares sold 1,000 Post-tra…
Key Points Interested in UFP Technologies, Inc.? Here are five stocks we like better. UFP Technologies targets 12%–18% annual growth through organic expansion and acquisitions, with long-term goals of 28%–31% gross margins and 17%–20% adju…
2 Profitable Stocks with Exciting Potential and 1 Facing Headwinds While profitability is essential, it doesn't guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies — as Jeff Be…
NEWBURYPORT, Mass., August 20, 2026--(BUSINESS WIRE)--UFP Technologies, Inc. (Nasdaq: UFPT),today announced Mitchell Rock, President and Chief Executive Officer, and Ron Lataille, Sr. Vice President, Treasurer and Chief Financial Officer,…
Company Logo urging global trade, e-commerce expansion, and strict protective packaging standards highlighted by UFP Technologies' record $174 million Q2 2026 sales, Zotefoams' 23% H1 revenue surge, and strategic scale across Sealed Air an…
The Top 5 Analyst Questions From UFP Technologies's Q2 Earnings Call UFP Technologies delivered a calendar second quarter marked by strong, broad-based growth across its MedTech platform, which exceeded Wall Street's revenue and profit exp…
(RTTNews) - The following biotech stocks reached a 52-week high on August 4, 2026, driven by key catalysts like positive quarterly results or certain regulatory milestones. UFP Technologies Inc. (UFPT) UFP Technologies is a contract develo…
Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. UFP Technologies (UFPT) is back in focus after reporting record Q2 2026 results, with sales of $1…
Key Points Interested in UFP Technologies, Inc.? Here are five stocks we like better. Strong second-quarter performance: UFP Technologies increased sales 15.1% to $174 million and adjusted EPS 16.8% to a record $2.92. Gross margin improved…
3 of Wall Street's Favorite Stocks with Warning Signs The stocks in this article have caught Wall Street's attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of sal…
(RTTNews) - UFP Technologies, Inc. (UFPT) revealed earnings for its second quarter that Increases, from last year The company's bottom line came in at $20.85 million, or $2.68 per share. This compares with $17.18 million, or $2.21 per shar…
UFP Technologies (UFPT) came out with quarterly earnings of $2.92 per share, beating the Zacks Consensus Estimate of $2.51 per share. This compares to earnings of $2.5 per share a year ago. These figures are adjusted for non-recurring item…
UFP Technologies's (NASDAQ:UFPT) Q2 CY2026: Strong Sales, Stock Soars Medical products company UFP Technologies (NASDAQ:UFPT) reported Q2 CY2026 results exceeding the market's revenue expectations , with sales up 15.1% year on year to $174…
NEWBURYPORT, Mass., August 03, 2026--(BUSINESS WIRE)--UFP Technologies, Inc. (Nasdaq: UFPT), a trusted contract development and manufacturing organization specializing in comprehensive solutions for medical devices, sterile packaging and o…
Earnings To Watch: UFP Technologies (UFPT) Reports Q2 Results Tomorrow Medical products company UFP Technologies (NASDAQ:UFPT) will be reporting results this Monday after market hours. Here's what you need to know. UFP Technologies met ana…
Conference Call Scheduled for August 4th at 8:30 AM ET NEWBURYPORT, Mass., July 29, 2026--(BUSINESS WIRE)--UFP Technologies, Inc. (Nasdaq: UFPT), a trusted contract development and manufacturing organization specializing in comprehensive s…
2 Reasons UFPT is Risky and 1 Stock to Buy Instead Over the past six months, UFP Technologies's shares (currently trading at $244.72) have posted a disappointing 8.2% loss, well below the S&P 500's 7.7% gain. This may have investors wonder…
1 Healthcare Stock with Solid Fundamentals and 2 We Brush Off Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Shareholders who bet on the industry have been rewarded lately a…
3 Hyped Up Stocks with Questionable Fundamentals Each stock in this article is trading near its 52-week high. These elevated prices usually indicate some degree of investor confidence, business improvements, or favorable market conditions.…
3 Small-Cap Stocks We Keep Off Our Radar Investors looking for hidden gems should keep an eye on small-cap stocks because they're frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a h…
1 Cash-Producing Stock to Target This Week and 2 Facing Headwinds A company that generates cash isn't automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. Not all companies a…
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at IQVIA (NYSE:IQV) and the best and worst performers in the drug development inputs…
Q1 Rundown: UFP Technologies (NASDAQ:UFPT) Vs Other Drug Development Inputs & Services Stocks Wrapping up Q1 earnings, we look at the numbers and key takeaways for the drug development inputs & services stocks, including UFP Technologies (…
Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. UFP Technologies (NasdaqCM:UFPT) has appointed Ryan Stafford as General Counsel and Senior Vice Pre…
The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However, these companies often come with higher volatility and risk, as their smaller size…